###### Strengths and limitations of this study

-   This scoping review has systematically mapped which outcome measures have been used by randomised controlled trials testing non-pharmacological treatments in mild dementia and mild cognitive impairment.

-   This review has explored how the use of outcome measures varies by diagnosis, type of intervention, country and year of publication.

-   The papers included in this review were limited to full randomised controlled trials, other study designs may be using different types of outcome measures.

-   Further research is needed to establish which measures should be used over others.

Introduction {#s1}
============

Delivery of both pharmacological and non-pharmacological treatment in the early stages of dementia has been identified as a global priority.[@R1] Current pharmacological treatments for the cognitive symptoms of dementia have been found to have a greater effect when delivered as early as possible.[@R3] However, the benefits of delivering non-pharmacological treatments early are less well understood. Non-pharmacological treatments are an important clinical tool for managing dementia as they are more acceptable to some and less prone to side effects, making them a safe alternative to drug treatments.[@R4] Those diagnosed earlier in the disease have more cognitive abilities available to engage with non-pharmacological treatments and bolster their own methods for coping with the disease.[@R5] Previous systematic reviews have found non-pharmacological treatments can improve outcomes; however, these reviews were restricted to a small number of outcome measures.[@R6]

Mild cognitive impairment (MCI) has been identified as a potential prodrome for dementia, with approximately 10% of people with MCI converting to a diagnosis of dementia per annum.[@R8] There is an interest in MCI, as a diagnosis of MCI can facilitate an early diagnosis of dementia and therefore earlier access to dementia services and treatment.[@R9] MCI is a potentially reversible condition, with many people with MCI reverting back to normal levels of cognition.[@R9] Therefore, it is important treatments are available. However, it is not clear which treatments can reverse MCI or prevent conversion to dementia.[@R3] No drug treatments for MCI have been found to be effective[@R10] and acetylcholinesterase inhibitors are not recommended, however, there is some limited evidence that non-pharmacological interventions may be beneficial.[@R3]

Randomised controlled trials (RCTs) testing non-pharmacological treatments in dementia and MCI are becoming more common. However, they are highly heterogeneous in terms of participants recruited, quality of the study and the types of interventions they are testing, making it difficult to establish the effectiveness of one treatment over another.[@R6] Compounding these issues is the inconsistent use of outcome measures in this area of work.[@R9]

Systematic reviews have identified possible benefits of non-pharmacological treatment, yet meta-analyses are difficult to conduct due to the variation in outcome measures used by studies and typically yield small-to-moderate effect sizes.[@R6] It is possible that these small effect sizes are due to the selection of outcome measures which either lack sensitivity or the change following the intervention not being in the area covered by the outcome measure. It is important researchers are clear on which domains their interventions are targeting, and which measures are best able to capture this change.[@R15] Pharmacological treatments target specific biological pathways underlying the disease; therefore, outcome measures have been chosen to reflect this and typically focus on cognitive and functional decline.[@R16] Non-pharmacological treatments generally do not target the underlying biological pathway of the disease therefore, outcome measures should theoretically differ between pharmacological and non-pharmacological treatments.[@R17] However, a review on non-pharmacological approaches to treating found that studies tended to pay little attention to the mechanisms of change underlying the intervention.[@R4] The expected mechanisms of change should affect which outcomes are used in non-pharmacological treatments for mild dementia and MCI.

In addition to being clear on how change arises in non-pharmacological treatments, there needs to be a more coherent use of outcomes and the measures used to capture these between studies to ensure a broad and robust evidence base.[@R15] In 2008, the INTERDEM group, a consortium of dementia researchers across Europe, did work to draw a consensus on which outcome measures should be used when evaluating non-pharmacological treatments. They recommended 22 measures across 9 domains including quality of life, mood, global functioning, behaviour, daily living skills, caregiver mood, caregiver burden and staff morale.[@R15] This guidance does not explore outcomes by the stage of the disease. The outcome measures were selected based on their applicability to European research. The utility of outcome measures may vary by culture,[@R16] previous reviews exploring the use of outcome measures in dementia research have not investigated how this differs by country.[@R17]

It is not understood which outcome measures are currently being used in non-pharmacological treatments for early dementia and MCI. Scoping reviews present the opportunity to map the evidence on a topic,[@R18] unlike a systematic review scoping reviews can be used to summarise the evidence in a heterogeneous body of literature. Therefore, the aim of this scoping review is to map trends in which outcome measures are being used in RCTs for non-pharmacological treatments in MCI and mild dementia.

Objectives {#s1-1}
----------

The specific objectives of this scoping review are to:

1.  Chart which outcomes measures have been used to assess the effectiveness of non-pharmacological treatments in mild dementia and MCI.

2.  Highlight which types of measures have been used most frequently.

3.  Explore whether the outcome measures used differ depending on the type of intervention, study population and country the research was conducted in.

Methods {#s2}
=======

Protocol registration {#s2-1}
---------------------

The protocol for this review was developed following the guidelines set out by the Preferred Reporting Items for Systematic Reviews and Meta-Analysis Extension (PRISMA) statement[@R19] and the PRISMA guidelines for Scoping Reviews.[@R18]

Eligibility criteria {#s2-2}
--------------------

We included RCTs testing non-pharmacological interventions for people diagnosed with MCI or mild dementia. Studies were restricted to full RCTs; observational, feasibility and pilot studies were not included.

Studies were included if they met the following criteria:

-   Testing non-pharmacological interventions. Studies were not excluded if participants were also treated with acetylcholinesterase inhibitors.

-   Participants had a diagnosis of MCI or mild dementia, which was either diagnosed in clinical practice, or met standardised diagnostic criteria, such as the International Statistical Classification of Diseases or The Diagnostic Statistical Manual of Mental Disorders, The National Institute of Communicative disorders and Stroke and the Alzheimer's Disease and Related Disorders, the International working group on MCI criteria, The Consortium to Establish a Registry for Alzheimer's Disease, The National Institute on Aging-Alzheimer's Associating Diagnostic Guidelines for Alzheimer's Disease, the Petersen Criteria; or was defined by a standardised clinical measure, such as scores between 24 and 18 on the Mini-Mental State Examination (MMSE); scores ≤26 on the Montreal Cognitive Assessment, scores between 15 and 27 on the St Louis University Mental Status, a Clinical Dementia Rating score of 1 (for dementia) or 0.5 (for MCI); or a 4 (for dementia) or 3 (for MCI) on the Global Deterioration Scale. Studies which include a mix of participants with early dementia and MCI were included, however, studies which included healthy participants and participants with dementia at the later stages of the disease were excluded.

-   The intervention was targeted for the person living with dementia or MCI. Dyadic interventions, interventions delivered to both the person living with dementia and their caregivers, were included. Interventions delivered solely to caregivers or healthcare professionals were excluded.

-   Participants were living in long-term care facilities or the community.

-   Written in English.

Studies were excluded if:

-   Only pharmacological interventions were tested.

-   The participants were diagnosed with vascular cognitive impairment, young-onset dementia, Parkinson's disease dementia or MCI with Parkinson's disease.

-   Participants were living in a psychiatric inpatient or acute hospital setting.

-   The intervention had the primary aim of treating major depressive disorder.

-   The study tested palliative care interventions or advanced care planning.

-   The only outcome measures used were economic outcomes, such as cost-effectiveness, etc.

Information sources and search strategy {#s2-3}
---------------------------------------

To identify potentially relevant studies, we searched EMBASE, PsychINFO, Medline and the Cochrane Register of Controlled Trials from inception until 22 February 2018. An additional search was conducted on 2 April 2019. See [online supplementary table 1](#SP1){ref-type="supplementary-material"} for the final search strategy for MEDLINE, which was adapted for the other databases. The final search results were exported into EndNote where duplicates were removed.
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Additional papers were identified by searching the references of included papers and other systematic reviews. Conference abstracts and publications were not included.

Selection of sources of evidence {#s2-4}
--------------------------------

Study selection was managed in Rayyan, where citations were screened against the inclusion and exclusion criteria. Rayyan is an online app for systematic reviews which allows researchers to create their own coding system for decision making.[@R20] References were first screened by title and abstract, followed by a full-text screening. A second reviewer (MC) screened 10% of the articles at each stage of the review. Disagreements were resolved by discussions with a third reviewer (AMP).

A critical appraisal or assessment of the risk of bias is not necessary for a scoping review.[@R18] This scoping review is not aiming to critically appraise the cumulative literature of outcome measures for non-pharmacological treatment in MCI and mild dementia, therefore we did not conduct a critical appraisal or risk of bias assessment for this review.

Data charting process and data items {#s2-5}
------------------------------------

Data from eligible studies were charted using a standardised extraction tool designed for this study. Items deemed most relevant to the review objectives were the diagnosis of the study participants, description of interventions being tested, the number of intervention groups and outcome measures used with references.

Synthesis of results {#s2-6}
--------------------

The charted data were mapped to reflect the objectives of this review. Following data charting, outcome measures which were used more than once across the included studies were grouped by domain. We grouped the interventions thematically by the type of intervention being tested.

We explored which types of outcome measures were used by intervention type, by tabulating the type of intervention against the domain of the outcome measure. We excluded interventions which were only used once from this summary. Results were presented in tables and summarised narratively.

Patient and participant involvement {#s2-7}
-----------------------------------

The South London and Maudsley MALADY group, of current and former carers of people living with dementia, were consulted in the planning of this study.

Results {#s3}
=======

Included studies {#s3-1}
----------------

After duplicates were removed, a total of 7056 citations were screened for inclusion, 653 were screened at full text and 74 papers were initially identified. A top-up search in April 2019 identified 119 new citations, 17 were included making the total number of included studies 91 ([figure 1](#F1){ref-type="fig"}).

![Flow chart of included studies.](bmjopen-2019-035980f01){#F1}

The studies included in this review are described in [table 1](#T1){ref-type="table"}, including diagnosis of included participants, number of intervention groups, details on the interventions and comparisons tested and the number of outcomes measures used. The included studies were published between 2002 and 2019.

###### 

Included studies

  Study                               Country           Diagnosis   Number of groups   Group 1                                                                            Group 2                                                  Group 3                                        Group 4          Group 5   Number of measures
  ----------------------------------- ----------------- ----------- ------------------ ---------------------------------------------------------------------------------- -------------------------------------------------------- ---------------------------------------------- ---------------- --------- --------------------
  Amjad *et al*[@R37]                 Pakistan          MCI         2                  Aerobic exercise                                                                   Non-aerobic exercise                                     --                                             --               --        4
  Bae *et al*[@R38]                   Japan             MCI         2                  Multi-intervention programme                                                       Active control                                           --                                             --               --        10
  Baker *et al*[@R39]                 USA               MCI         2                  Aerobic exercise                                                                   Stretching                                               --                                             --               --        11
  Belleville *et al*[@R40]            Canada            MCI         3                  Cognitive training                                                                 Psychosocial intervention                                Control                                        --               --        7
  Biasutti and Mangiacotti[@R41]      Italy             MCI         2                  Cognitive training                                                                 Gym activities                                           --                                             --               --        4
  Bono *et al*[@R42]                  Italy             MCI         2                  Animal assisted therapy                                                            Control                                                  --                                             --               --        4
  Burgio *et al*[@R43]                Italy             MCI         2                  Numerical training                                                                 Executive training                                       --                                             --               --        13
  Buschert *et al*[@R44]              Germany           MCI         2                  Cognitive training                                                                 Active control                                           --                                             --               --        5
  Carretti *et al*[@R45]              Italy             MCI         2                  Cognitive training                                                                 Active control                                           --                                             --               --        16
  Cavallo *et al*[@R46]               Italy             Dementia    2                  Cognitive training                                                                 Active control                                           --                                             --               --        3
  Chan *et al*[@R47]                  Hong Kong         MCI         2                  Chinese calligraphy                                                                Computer activities                                      --                                             --               --        13
  Chan *et al*[@R48]                  Hong Kong         MCI         2                  Chinese calligraphy                                                                Computer activities                                      --                                             --               --        8
  Choi and Lee[@R49]                  South Korea       MCI         2                  Ground kayaking                                                                    Home exercise education                                  --                                             --               --        7
  Combourieu Donnezan *et al*[@R50]   France            MCI         4                  Physical training                                                                  Cognitive training                                       Simultaneous cognitive and physical training   Control          --        4
  DiNapoli *et al*[@R51]              USA               MCI         2                  Individualised social activities                                                   Control                                                  --                                             --               --        4
  Doi *et al*[@R52]                   Japan             MCI         2                  Exercise                                                                           Active control                                           --                                             --               --        4
  Doi *et al*[@R53]                   Japan             MCI         3                  Dance                                                                              Playing musical instruments                              Health education group                         --               --        4
  Drumond Marra *et al*[@R54]         Brazil            MCI         2                  TMS                                                                                Sham TMS                                                 --                                             --               --        6
  Emsaki *et al*[@R55]                Iran              MCI         2                  Cognitive training                                                                 Active control                                           --                                             --               --        9
  Eyre *et al*[@R56]                  USA               MCI         2                  Yoga                                                                               Cognitive training                                       --                                             --               --        10
  Feng *et al*[@R57]                  China             MCI         2                  Single component cognitive training                                                Multiple component cognitive training                    --                                             --               --        3
  Fernández-Calvo *et al*[@R58]       Spain             Dementia    2                  Multi-intervention programme                                                       Control                                                  --                                             --               --        21
  Fiatarone Singh *et al*[@R59]       Australia         MCI         4                  Progressive resistance training and sham cognitive training                        Progressive resistance training and cognitive training   Cognitive training                             Control          --        12
  Finn and McDonald[@R60]             Australia         MCI         2                  Repetition-lag training                                                            Control                                                  --                                             --               --        6
  Fogarty *et al*[@R61]               Canada            MCI         2                  Memory intervention programme and tai chi                                          Memory intervention programme                            --                                             --               --        5
  Förster *et al*[@R62]               Germany           Both        2                  Cognitive training                                                                 Control                                                  --                                             --               --        10
  Galante *et al*[@R63]               Italy             Dementia    2                  Cognitive training                                                                 Active control                                           --                                             --               --        12
  Greenaway *et al*[@R21]             USA               MCI         2                  Memory support system (memory rehabilitation) with training                        Memory support system without training                   --                                             --               --        15
  Hagovská *et al*[@R64]              Czech Republic    MCI         2                  Cognitive training (computer based)                                                Cognitive training                                       --                                             --               --        0
  Hagovská *et al*[@R65]              Czech Republic    MCI         2                  Cognitive training and dynamic balance training                                    Balance training                                         --                                             --               --        4
  Han *et al*[@R66]                   South Korea       MCI         2                  Ubiquitous spaced retrieval-based memory advancement and rehabilitation training   Control                                                  --                                             --               --        4
  Han *et al*[@R67]                   South Korea       Both        2                  Multimodal cognitive enhancement therapy                                           Active control                                           --                                             --               --        7
  Hattori *et al*[@R29]               Japan             Dementia    2                  Art therapy                                                                        Active control                                           --                                             --               --        4
  Ho *et al*[@R68]                    Hong Kong         Both        3                  Dance movement therapy                                                             Physical exercise                                        Control                                        --               --        7
  Horie *et al*[@R69]                 Brazil            MCI         2                  Group weight loss programme                                                        Control                                                  --                                             --               --        10
  Hyer *et al*[@R70]                  USA               MCI         2                  Cognitive training (computer based)                                                Active control                                           --                                             --               --        3
  Jansen *et al*[@R22]                The Netherlands   Dementia    2                  Case management                                                                    Control                                                  --                                             --               --        5
  Jean *et al*[@R71]                  Canada            MCI         2                  Cognitive training                                                                 Active control                                           --                                             --               --        10
  Jelcic *et al*[@R72]                Italy             Dementia    2                  Lexical-semantic treatment                                                         Cognitive stimulation                                    --                                             --               --        11
  Jeong *et al*[@R73]                 South Korea       MCI         2                  Cognitive intervention (group based)                                               Cognitive intervention (home based)                      --                                             --               --        8
  Kinsella *et al*[@R23]              Australia         MCI         2                  Cognitive intervention                                                             Control                                                  --                                             --               --        4
  Kohanpour *et al*[@R74]             Iran              MCI         4                  Aerobic exercise                                                                   Lavender extract                                         Aerobic exercise and lavender extract          Control          --        14
  Koivisto *et al*[@R24]              Finland           Dementia    2                  Psychosocial intervention                                                          Control                                                  --                                             --               --        7
  Kovács *et al*[@R75]                Hungary           MCI         2                  Multimodal exercise                                                                Control                                                  --                                             --               --        1
  Küster *et al*[@R76]                Germany           MCI         3                  Cognitive training                                                                 Physical training                                        Control                                        --               --        7
  Kwok *et al*[@R77]                  Hong Kong         MCI         2                  Cognitive training                                                                 Active control                                           --                                             --               --        5
  Lam *et al*[@R78]                   Hong Kong         MCI         2                  Tai Chi                                                                            Stretching                                               --                                             --               --        4
  Lam *et al*[@R79]                   Hong Kong         MCI         4                  Cognitive training                                                                 Cognitive and physical training                          Physical training                              Social groups    --        2
  Lam *et al*[@R25]                   Hong Kong         Dementia    2                  Case management                                                                    Control                                                  --                                             --               --        2
  Langoni *et al*[@R80]               Brazil            MCI         2                  Group exercise                                                                     Control                                                  --                                             --               --        14
  Law *et al*[@R81]                   Hong Kong         MCI         2                  Functional tasks exercise programme                                                Cognitive training                                       --                                             --               --        7
  Lazarou *et al*[@R82]               Greece            MCI         2                  Ballroom dancing                                                                   Control                                                  --                                             --               --        5
  Li *et al*[@R83]                    China             MCI         2                  Computerised cognitive training                                                    Control                                                  --                                             --               --        4
  Lim *et al*[@R84]                   Singapore         MCI         2                  Mindfulness                                                                        Health education                                         --                                             --               --        5
  Logsdon *et al*[@R26]               USA               Dementia    2                  Early stage memory loss support group                                              Control                                                  --                                             --               --        10
  Luijpen *et al*[@R85]               The Netherlands   MCI         2                  TENS                                                                               Sham TENS                                                --                                             --               --        6
  Maffei *et al*[@R86]                Italy             MCI         2                  Multidomain training                                                               Control                                                  --                                             --               --        10
  İnel Manav and Simsek[@R87]         Turkey            Dementia    2                  Reminiscence therapy                                                               Social interview                                         --                                             --               --        6
  Melendez *et al*[@R88]              Spain             Both        2                  Reminiscence therapy                                                               Control                                                  --                                             --               --        6
  Nagamatsu *et al*[@R89]             Canada            MCI         2                  Aerobic exercise                                                                   Resistance training                                      --                                             --               --        13
  Olsen *et al*[@R90]                 Norway            Both        2                  Animal-assisted therapy                                                            Control                                                  --                                             --               --        9
  Pantoni *et al*[@R91]               Italy             MCI         2                  Attention process training                                                         Control                                                  --                                             --               --        4
  Park and Park[@R92]                 South Korea       MCI         2                  Cognition-specific computer training                                               Non-specific computer training                           --                                             --               --        5
  Poinsatte *et al*[@R93]             USA               MCI         2                  Aerobic exercise                                                                   Stretching                                               --                                             --               --        3
  Pongan *et al*[@R94]                France            Dementia    2                  Choral singing                                                                     Painting                                                 --                                             --               --        14
  Poptsi *et al*[@R95]                Greece            MCI         5                  Paper language tasks                                                               Computer language tasks                                  Oral language tasks                            Active control   Control   4
  Qi *et al*[@R96]                    China             MCI         2                  Aerobic exercise                                                                   Control                                                  --                                             --               --        3
  Rapp *et al*[@R97]                  USA               MCI         2                  Memory enhancement training (multicomponent)                                       Control                                                  --                                             --               --        9
  Rojas *et al*[@R98]                 Argentina         MCI         2                  Cognitive intervention                                                             Control                                                  --                                             --               --        8
  Rozzini *et al*[@R99]               Italy             MCI         2                  Cognitive training and AChEIs                                                      AChEIs                                                   --                                             --               --        7
  Savulich *et al*[@R100]             UK                MCI         2                  Cognitive training                                                                 Control                                                  --                                             --               --        9
  Scherder *et al*[@R101]             The Netherlands   MCI         3                  Walking                                                                            Hand and face exercises                                  Control                                        --               --        11
  Shimada *et al*[@R102]              Japan             MCI         2                  Physical and cognitive training                                                    Health education group                                   --                                             --               --        7
  Shimizu *et al*[@R103]              Japan             MCI         2                  Movement music therapy                                                             Single training task                                     --                                             --               --        4
  Simon *et al*[@R104]                Brazil            MCI         2                  Memory training                                                                    Active control                                           --                                             --               --        8
  Song *et al*[@R105]                 China             MCI         2                  Aerobic exercise                                                                   Active control                                           --                                             --               --        4
  Suzuki *et al*[@R106]               Japan             MCI         2                  Multicomponent exercise group                                                      Active control                                           --                                             --               --        6
  Tappen and Hain[@R27]               USA               Both        2                  Cognitive training (home based)                                                    Life story interview                                     --                                             --               --        11
  Troyer *et al*[@R107]               Canada            MCI         2                  Multicomponent intervention                                                        Control                                                  --                                             --               --        6
  Tsai *et al*[@R108]                 Taiwan            MCI         3                  Aerobic exercise                                                                   Resistance training                                      Control                                        --               --        7
  Tsantali *et al*[@R109]             Greece            Dementia    3                  Cognitive training                                                                 Cognitive stimulation                                    Control                                        --               --        5
  van Uffelen *et al*[@R110]          The Netherlands   MCI         4                  Walking                                                                            Placebo activity                                         Folic acid/Vitamin b supplements               Placebo pills    --        3
  Waldorff *et al*[@R28]              Denmark           Dementia    2                  Multifaceted counselling, education and support                                    Control                                                  --                                             --               --        2
  Wei *et al*[@R111]                  China             MCI         2                  Handball training                                                                  Control                                                  --                                             --               --        8
  Yang *et al*[@R112]                 USA               MCI         2                  Memory enhancement training                                                        Yoga                                                     --                                             --               --        3
  Yoon *et al*[@R113]                 South Korea       MCI         2                  High-speed power strength training                                                 Low-speed strength training                              --                                             --               --        5
  Young *et al*[@R114]                Hong Kong         Dementia    2                  Support groups                                                                     Control                                                  --                                             --               --        4
  Young *et al*[@R115]                Hong Kong         MCI         2                  Holistic health group                                                              Control                                                  --                                             --               --        4
  Yun *et al*[@R116]                  South Korea       MCI         2                  TDS                                                                                Sham TDS                                                 --                                             --               --        1
  Zhao *et al*[@R117]                 China             MCI         2                  Creative expression therapy                                                        Cognitive training                                       --                                             --               --        7
  Zhu *et al*[@R118]                  China             MCI         2                  Dance                                                                              Control                                                  --                                             --               --        7

MCI, mild cognitive impairment; TDS, transcranial direct current stimulation; TENS, transcutaneous electrical nerve stimulation; TMS, transcranial magnetic stimulation.

The majority of studies included in this review were conducted in the USA (n=10), Hong Kong (n=10) and Italy (n=11), followed by mainland China (n=7), Japan (n=8), South Korea (n=8) and Canada (n=6). Studies were also conducted in: Argentina, Australia, Brazil, Czech Republic, Denmark, France, Finland, Germany, Greece, Hungary, Iran, Norway, Pakistan, Singapore, Spain, Taiwan, The Netherlands, Turkey and the UK; these countries had fewer than five included studies each.

Most studies only recruited participants with MCI (n=71), followed by mild dementia only (n=14), and six studies recruited both participants with MCI and mild dementia.

Results of individual sources of evidence {#s3-2}
-----------------------------------------

We extracted 358 individual outcome measures from the included studies, of these 78 (22%) were used more than once. Out of the 78 measures used more than once, 70 (88%) were measures of participants living with dementia (PLWD), 6 measures were used in both the PLWD and their caregiver, 2 measures were only of the caregiver. The number of outcome measures used by each study ranged between 1 and 21 with an average of 6.85.

Types of non-pharmacological interventions {#s3-3}
------------------------------------------

We grouped the interventions thematically by type. The most frequently tested type of intervention was cognitive training (n=37) followed by physical activity (n=25), combined physical activity and cognitive training (n=4), multicomponent psychosocial interventions (n=4) and support groups (n=3). Animal-assisted therapies, art-based therapies, case management, Chinese calligraphy, music-based interventions and reminiscence therapy were each tested in two studies.

A group weight loss programme, mindfulness, social activities, transcranial direct current stimulation, transcutaneous electrical nerve stimulation and Transcranial magnetic stimulation were each trialled once. These interventions were not included in the analysis of trends in outcome measures.

PLWD outcome measures {#s3-4}
---------------------

[Table 2](#T2){ref-type="table"} presents the PLWD-specific outcome measures grouped by domain. The most frequently measured domain in PLWD was cognition/memory, which was measured 219 times across the 93 included studies. The most frequent measure of cognition was the MMSE, which was measured 37 times. In addition to measures of memory performance, knowledge of memory strategies was measured 3 times in PLWD.

###### 

Outcome measures by domain and subdomains

  ------------------------------------------------------------------------------------------------------------------------------------------------------
  Person living with dementia measures\                    Outcome measure                                                                     N
  Domain and subdomain                                                                                                                         
  -------------------------------------------------------- ----------------------------------------------------------------------------------- ---------
  **Cognition/Memory**                                                                                                                         **219**

  Cognition                                                MMSE                                                                                37

                                                           Trail Making Test                                                                   27

                                                           Digit Span Test                                                                     12

                                                           ADAS-Cog                                                                            10

                                                           Rey Auditory Test                                                                   9

                                                           Rivermead Behavioural Memory Test                                                   9

                                                           Stroop Test                                                                         7

                                                           MMQ                                                                                 7

                                                           Novelli Lexical Test                                                                7

                                                           MoCA                                                                                6

                                                           CDR                                                                                 6

                                                           Verbal Fluency                                                                      6

                                                           CERAD-NB                                                                            5

                                                           Addenbrooke\'s Cognitive Examination                                                4

                                                           Boston Naming Test                                                                  4

                                                           Rey Osterrieth Complex Figure Task                                                  4

                                                           Montreal Cognitive Test                                                             3

                                                           Attentional Matrices Test                                                           3

                                                           California Verbal Learning Test                                                     3

                                                           Digit Symbol Coding Test                                                            3

                                                           Hopkins Verbal Learning Test                                                        3

                                                           The Wechsler Memory Scale                                                           3

                                                           CAMcog                                                                              2

                                                           Cognitive Failures Test                                                             2

                                                           Colour Trails Test                                                                  2

                                                           Dementia Rating Scale-2                                                             2

                                                           DSM IV Test                                                                         2

                                                           Auditory Verbal Learning Test                                                       2

                                                           Corsi\'s Block Tapping Test                                                         2

                                                           Frontal Assessment Test                                                             2

                                                           Fuld Object Memory Evaluation                                                       2

                                                           Logical Memory (Subtest of Wechsler Memory Scale)                                   2

                                                           Prospective and Retrospective Memory Questionnaire                                  2

                                                           Pyramids & Palm Trees                                                               2

                                                           Questionnaire d'Auto Evaluation de la Memoire                                       2

                                                           Raven's Coloured Matrices                                                           2

                                                           Repeatable Battery Test                                                             2

                                                           The verbal learning and memory test                                                 2

                                                           Visual Memory Span                                                                  2

                                                           Wechsler Adult Intelligence Scale                                                   2

  Knowledge of memory strategies                           Memory Strategy Toolbox                                                             2

                                                           Strategy Knowledge Repertoire                                                       1

  Attention                                                Test of Everyday Attention                                                          2

  **Behavioural and psychological symptoms of dementia**   **51**                                                                              

  Anxiety/Depression                                       Geriatric Depression Scale\*                                                        21

                                                           Cornell Scale for Depression in Dementia\*                                          7

                                                           Hospital Anxiety and Depression Scale                                               4

                                                           Beck Depression Inventory                                                           1

  Other                                                    Neuropsychiatric Inventory\*                                                        12

                                                           Apathy Evaluation Scale                                                             3

                                                           Revised memory and behaviour problem checklist\*                                    

  **Everyday living**                                                                                                                          **20**

  Activities of daily living                               Instrumental Activities of Daily Living\*                                           8

                                                           Bayer Activities of Daily Living Scale                                              3

                                                           Alzheimer\'s Disease Cooperative Study Activities of Daily Living Scale             2

                                                           Barthel Index                                                                       2

  Functional ability                                       Functional Activities Questionnaire                                                 3

                                                           Functional and Cognitive Assessment Test and Functional Rating Scale for Dementia   2

  **Physical outcomes**                                                                                                                        **19**

  Physical performance                                     Timed Up and Go Test                                                                7

                                                           Gait                                                                                3

                                                           Handgrip strength                                                                   3

                                                           Stride                                                                              2

                                                           Walking Speed                                                                       2

  Physical measures                                        Weight                                                                              2

  **Quality of life/Well-being**                                                                                                               **15**

  Quality of life                                          QoL in Alzheimer's disease\*                                                        7

                                                           Dementia Quality of Life Instrument\*                                               3

                                                           EuroQoL EQ 5D\*                                                                     2

                                                           EQ-VAS                                                                              1

  Stress                                                   Perceived Stress Scale                                                              1

  General Well-being                                       SF-36                                                                               1

  **Biological outcome**                                   **9**                                                                               

  Brain activity                                           EEG                                                                                 4

                                                           MRI                                                                                 2

  Biomarker                                                BDNF                                                                                3

  **Adherence to intervention**                                                                                                                **2**

  Adherence to intervention                                Adherence                                                                           2

  **Caregiver measures**\                                  **Outcome measure**                                                                 **N**
  **domain**                                                                                                                                   

  **Depression**                                                                                                                               **5**

                                                           The Center for Epidemiological Studies Depression Scale\*                           3

                                                           Geriatric Depression Scale                                                          1

                                                           Beck Depression Inventory                                                           1

  **Caregiver burden**                                                                                                                         **2**

                                                           Zarit caregiver burden interview\*                                                  2

  **General well-being**                                                                                                                       **1**

                                                           SF-36\*                                                                             1

                                                                                                                                               

  **Knowledge of memory strategies**                                                                                                           **1**

                                                           Strategy Knowledge Repertoire                                                       1

  **Quality of life**                                                                                                                          **1**

                                                           EQ-VAS                                                                              1

  **Stress**                                                                                                                                   **1**

                                                           Perceived Stress Scale                                                              1
  ------------------------------------------------------------------------------------------------------------------------------------------------------

\*Measure recommended by INTERDEM Consensus.[@R14]

CDR, Clinical Dementia Rating; CERAD-NB, Consortium to Establish a Registry for Alzheimer's Disease- Neuropsychological Battery; DSM, Diagnostic Statistical Manual of Mental Disorders; EEG, electroencephalogram; EQ-VAS, EuroQoL Visual Analogue Scales; EuroQoL EQ 5D, EuroQoL 5-dimension; MMQ, Multifactorial Memory Questionnaire; MMSE, Mini-Mental State Examination; MoCA, Montreal Cognitive Assessment; SF-36, 36-Item Short Form Survey.

The next most frequently measured domain in PLWD was behavioural and psychological symptoms of dementia (BPSD), within this depression was the most commonly measured BPSD. The Geriatric Depression Scale was the most used measure in this domain, followed by the Neuropsychiatric Inventory which examines a greater number of symptoms. Other BSPDs measured were apathy and agitation resulting from memory problems.

Quality of life and well-being were measured 15 times across the included studies. Quality of life was measured 15 times using four different instruments, the most popular of which was Logsdon's Quality of Life in Alzheimer's disease scale which was used 7 times.

Measures of everyday living, physical ability, biological outcomes and adherence to the intervention delivered in the study were measured \<20 times across the included studies.

Caregiver measures {#s3-5}
------------------

Eight interventions in this study were dyadic,[@R21] all included outcome measures specific to the caregiver in addition to the PLWD. One study of an intervention solely delivered to the PLWD also included a caregiver-specific measure.[@R29]

[Table 2](#T2){ref-type="table"} also presents the outcome measures administered to caregivers grouped by domain. The Center for Epidemiological Studies Depression Scale and the Zarit Caregiver Burden interview were the only measures which were administered solely to caregivers. The other caregiver measures were also administered to PLWD. The most frequently measured domain in caregivers was depression, followed by caregiver burden. General well-being, knowledge of memory strategies, quality of life and stress were each measured once.

Use of outcome measures over time {#s3-6}
---------------------------------

RCTs of non-pharmacological treatments in mild dementia and MCI have become more frequent over recent years. Almost half (48%) of studies included in this review were published between 2016 and 2018.

[Figure 2](#F2){ref-type="fig"} charts trends in outcome measure domains over time. As the number of studies in this area has increased over time, so too has the use of outcome measures in all domains. Cognition/memory has consistently been measured over other domains from the beginning of this sample. The only noticeable trend change is in measures of BPSD, which was generally in line with other domains until around 2012, when it overtakes other domains.

![Trends in outcome measures over time. BPSD, behavioural and psychological symptoms of dementia; QoL, quality of life.](bmjopen-2019-035980f02){#F2}

Nearly all studies in 2014 included a measure of everyday living; however, since then, the number of studies including these measures has declined. Where measures of everyday living are being used less, measures of BPSD are being used more.

Similarly, caregiver measures were consistently used until 2011, when in 2010 and 2011 all studies included a caregiver measure, however since then the use of such measures has declined.

Use of outcome measures by intervention {#s3-7}
---------------------------------------

[Table 3](#T3){ref-type="table"} presents diagnosis and type of intervention by the domains measured. Cognition/memory was the most measured domain across all diagnostic groups, followed by BPSD. The third most common domain for MCI studies was physical performance, whereas caregiver measures were the third most common type of measures used in studies of early dementia.

###### 

Outcome measure domain by diagnosis and intervention

                                             Number of studies   BPSD   Biological outcome   Caregiver measure   Cognition/Memory   Everyday living   Physical measures   Physical performance   Quality of life/Well-being   Task performance
  ------------------------------------------ ------------------- ------ -------------------- ------------------- ------------------ ----------------- ------------------- ---------------------- ---------------------------- ------------------
  **Diagnosis**                                                                                                                                                                                                               
  Both                                       6                   5      --                   1                   12                 1                 --                  --                     --                           --
  Dementia                                   14                  16     --                   7                   42                 6                 --                  --                     6                            --
  MCI                                        71                  30     9                    3                   163                12                2                   17                     9                            2
  **Type of intervention**                                                                                                                                                                                                    
  Animal-assisted therapy                    2                   2      --                   --                  2                  1                 --                  --                     --                           --
  Art-based therapy                          2                   1      --                   1                   6                  1                 --                  --                     --                           --
  Case management                            2                   2      --                   3                   1                  --                --                  --                     1                            --
  Chinese calligraphy                        2                   1      1                    --                  4                  --                --                  --                     --                           --
  Cognitive training                         37                  23     2                    3                   103                11                --                  1                      6                            2
  Cognitive training and physical activity   4                   --     --                   --                  14                 2                 --                  2                      --                           --
  Multicomponent psychosocial intervention   4                   6      --                   3                   10                 2                 --                  2                      3                            --
  Music-based intervention                   2                   1      --                   --                  7                  --                1                   2                      1                            --
  Physical activity                          25                  11     6                    --                  53                 3                 1                   10                     2                            --
  Reminiscence therapy                       2                   1      --                   --                  2                  --                --                  --                     --                           --
  Support group                              3                   3      --                   1                   1                  --                --                  --                     1                            --

BPSD, behavioural and psychological symptoms of dementia; MCI, mild cognitive impairment.

Cognition/memory was measured in all types of intervention. Measures of BPSD were most common in cognitive training interventions and physical activity interventions, however, they were not used by combined cognitive and physical training interventions. Quality of life was measured by studies of case management, cognitive training, psychosocial interventions, physical activity and support groups.

Caregiver measures were used in five types of interventions: case management, cognitive training and psychosocial interventions; followed by arts-based therapy and support groups.

Use of outcome measures by country {#s3-8}
----------------------------------

[Table 4](#T4){ref-type="table"} presents the country the research was conducted in by outcome measure domain. Generally, there was not much variability in the domain of outcome measures used by country. Cognition/memory was the domain most frequently measured by all countries, followed by BPSD. The majority of studies were conducted in China (including Hong Kong and Taiwan), these studies focused on cognition/memory, BPSD and biological outcome measures. Other than China, only three other countries included biological measures (Iran, Pakistan and the USA). The USA had the second largest number of studies included in this review, these studies favoured cognition/memory, BPSD, caregiver measures and quality of life. Out of the 24 countries with studies included in this review, less than half (n=9) included measures of quality of life.

###### 

Outcome measure domain by country

  Country                                Number of studies   BPSD   Biological outcome   Caregiver measure   Cognition/Memory   Functional ability   Physical measures   Physical performance   Quality of life/Well-being   Task performance
  -------------------------------------- ------------------- ------ -------------------- ------------------- ------------------ -------------------- ------------------- ---------------------- ---------------------------- ------------------
  Argentina                              1                   1      0                    0                   6                  1                    0                   0                      0                            0
  Australia                              4                   0      0                    1                   5                  1                    0                   0                      0                            0
  Brazil                                 5                   1      1                    0                   14                 0                    0                   1                      0                            0
  Canada                                 6                   2      0                    0                   16                 0                    0                   2                      0                            0
  Mainland China, Hong Kong and Taiwan   20                  10     5                    1                   35                 2                    0                   0                      0                            1
  Czech Republic                         3                   0      0                    0                   3                  2                    0                   1                      0                            0
  Denmark                                1                   2      0                    2                   1                  1                    0                   0                      2                            0
  Finland                                1                   1      0                    1                   3                  1                    0                   0                      1                            0
  France                                 3                   1      0                    0                   6                  0                    0                   2                      1                            0
  Germany                                4                   1      0                    0                   10                 0                    0                   0                      1                            0
  Greece                                 4                   3      0                    0                   18                 2                    0                   0                      1                            0
  Hungary                                1                   0      0                    0                   0                  0                    0                   1                      0                            0
  Iran                                   3                   1      1                    0                   3                  0                    1                   0                      0                            0
  Italy                                  11                  8      0                    0                   32                 6                    0                   0                      1                            0
  Japan                                  8                   2      0                    1                   16                 1                    1                   6                      0                            0
  Norway                                 1                   1      0                    0                   1                  0                    0                   0                      0                            0
  Pakistan                               1                   0      1                    0                   3                  0                    0                   0                      0                            0
  Singapore                              1                   0      0                    0                   0                  0                    0                   0                      0                            0
  South Korea                            8                   5      0                    0                   14                 1                    0                   4                      3                            0
  Spain                                  3                   2      0                    0                   2                  0                    0                   0                      0                            0
  The Netherlands                        5                   0      0                    2                   10                 0                    0                   0                      2                            0
  Turkey                                 1                   1      0                    0                   1                  0                    0                   0                      0                            0
  UK                                     1                   3      0                    0                   1                  0                    0                   0                      0                            0
  USA                                    10                  6      1                    3                   19                 2                    0                   0                      3                            1

BPSD, behavioural and psychological symptoms of dementia.

Discussion {#s4}
==========

In this study, we used a scoping review to map which outcome measures had been used in trials for non-pharmacological treatments of mild dementia and MCI. We extracted 358 individual outcome measures used in 91 trials, only 22% of which were used more than once. We grouped the outcome measures which had been used more than once and examined differences in their use over time, by diagnostic group, country the research was set in and by the type of intervention they were being used to evaluate. Measures of cognition and BPSDs were the most frequently used across all studies and types of intervention.

Perhaps unsurprisingly, measures of cognition or memory are the most prevalent across all countries, diagnostic groups and types of intervention with the MMSE being the most frequently used outcome measure, despite the ADAS-cog having been validated as the gold-standard measure of cognition.[@R15] Measuring cognition is central to measuring the progression of dementia and is a clinically and empirically useful outcome to measure in dementia research.[@R31] However, in this review, we charted 40 different measures of cognition. This indicates that while cognition has been prioritised as an outcome in studies of non-pharmacological interventions, there is no consensus between researchers on which specific measures should be used. In addition to measures of cognitive performance, three studies have also measured participant's knowledge or retention of memory strategies, indicating an interest in long-term coping strategies for memory loss.

Measures of the BPSD have become more common over time, becoming in 2017 the most measured outcome after cognition. There is not much variety in the BPSDs which have been measured. Generally, depression was measured over other BPSDs. Other BPSDs such as agitation were measured less, perhaps because they are more associated with the later stages of the disease and depression is associated with the earlier stages.[@R32]

Quality of life and well-being were not among the most measured domains. Four measures of quality of life were used 15 times across the included studies and all but one of these measures were dementia-specific measures. It is surprising quality of life has not been measured more, as previous research has stated that in the absence of a cure, healthcare providers have a greater ability to improve quality of life than alter the progression of the disease.[@R33] Furthermore, both people with MCI and caregivers rated quality of life of the patient as the most important outcome to measure, followed by caregiver quality of life/burden.[@R34] Indicating while quality of life has been identified as a priority by PLWD, people diagnosed with MCI and their caregivers in previous research, the findings of this study shows this is not being translated into trials of non-pharmacological treatments for early dementia and MCI.

Likewise, caregiver measures had consistent low use across the studies included in this review. We charted eight caregiver measures which were used 11 times across the included studies. Caregiver measures were more commonly used in studies of PLWD, rather than MCI. Previous research has highlighted the profound effect of dementia on their caregivers, with around half of caregivers experiencing high levels of burden.[@R35] However, a third of caregivers of people with MCI also report extreme levels of burden,[@R36] yet the findings of this study show this is less investigated.

There was great variability in the types of outcomes being used to evaluate the different types of intervention. All studies measured cognition and all but one measured BPSD. A lack of clarity in how change occurs as a result of non-pharmacological treatments is a fundamental weakness in this area of work.[@R4] It is unlikely that all interventions being tested in this review could hope to improve cognition, however this is the most prevalent domain of outcome measures. There are a number of practical reasons as to why certain outcomes, and therefore outcome measures are used over others, In the past, pharmacological treatments have been required to include some measure of cognition, functional or global assessment,[@R17] it is possible that this approach has influenced the choice in outcomes used in non-pharmacological studies. Furthermore, some measures may be used over others for more practical reasons. For example, measures which are short to administer and free to use may be priorities over others.[@R31] Several interventions in this review comprise more than one component, for example, physical activity and cognitive training. In these cases, it may take multiple measures over many domains to accurately capture change. It is vital that outcome measures are selected depending on the domains the intervention is seeking to address.[@R31]

In 2008, the INTERDEM group recommended 22 outcome measures for use across 9 domains.[@R15] We found 11 of these 22 measures (50%) were used by the studies included in this review, one of the recommended domains (staff carer morale) was not applicable to the studies included in this review. All measures recommended for measuring patient mood, and patient quality of life were charted in this review. Only one of the recommended measures for the activities of daily living, caregiver mood, caregiver burden and caregiver quality of life domains were charted and no measures under the global measures domain were charted in this review. This indicates that there is some consistency between which measures are recommended and which measures are used, this is largely for patient measures and there is less consistency for caregiver measures.

In this study, we found that the use of outcome measures did not vary much by the country the study was conducted in. In each country, cognition/memory was the most commonly tested domain, followed by BPSD. The importance of outcomes may vary between cultures; therefore, it is important that the outcomes and measures used reflect this.[@R16] However, due to the limitations of the methodology used we cannot comment on the cultural relevance of the outcome measures charted in this review. Furthermore, articles were only included if they were published in English. It is possible that more culturally appropriate outcomes were used in articles published in the same language as the population under investigation. This is an important area for future research.

Limitations {#s4-1}
-----------

The findings of this review must be interpreted in the context of the study. To make this review feasible we only included full RCTs, other outcome measures may have been used in different types of studies. Due to time constraints, some subtypes of dementia and cognitive impairment (young-onset, Parkinson's disease dementia and vascular cognitive impairment) were excluded from this review, which limits the applicability of these findings. Further research is needed to explore whether the pattern in the use of outcomes and outcome measures is similar in these groups, compared with the ones included in this review. Furthermore, only outcome measures which were published could be included in this review. The studies included in this study were heterogeneous in terms of participants recruited, interventions tested and outcome measures used, making it difficult to group them thematically. It is possible some nuance is lost in the exploration of broader themes. As with the nature of scoping reviews, we are only able to present which outcome measures have been used in previous research, we are unable to draw conclusions as to which outcome measures should be used over others. Future research should explore which population measures have been validated for and what constitutes a clinically useful change.

Implications and recommendations for future research {#s4-2}
----------------------------------------------------

The findings of this review indicate there is very little consistency in outcome measures used in RCTs for non-pharmacological interventions in MCI and mild dementia, however we are not able to conclude which measures should be used over others. To create a strong evidence base for non-pharmacological treatments more research, with the involvement of PLWD and their carers, is needed to determine which measures are preferable over a greater number of domains. Additionally, the prevalence of cognitive measures found in this study suggests that researchers are including such measures because there is an expectation to do so. Researchers should be clear on the theory behind how their intervention creates change and use the appropriate outcome measures.

Conclusions {#s5}
===========

In summary, this study has found RCTs for non-pharmacological treatments in mild dementia and MCI use a broad range of outcome measures, with a small proportion being used more than once. Excepting measures of cognition, there is very little commonality between studies. Where previous research has set priorities on outcomes preferred by PLWD, people with MCI and caregivers, quality of life, for example, this has not yet translated into studies measuring new treatments. Further research is needed to understand which outcomes should be prioritised and how they should be measured.
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